166 related articles for article (PubMed ID: 23807847)
1. Non-ionic surfactant vesicles simultaneously enhance antitumor activity and reduce the toxicity of cantharidin.
Han W; Wang S; Liang R; Wang L; Chen M; Li H; Wang Y
Int J Nanomedicine; 2013; 8():2187-96. PubMed ID: 23807847
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effects of cantharidin in A431 human skin cancer (Epidermoid carcinoma) cells in vitro and in vivo.
Li CC; Yu FS; Fan MJ; Chen YY; Lien JC; Chou YC; Lu HF; Tang NY; Peng SF; Huang WW; Chung JG
Environ Toxicol; 2017 Mar; 32(3):723-738. PubMed ID: 27113412
[TBL] [Abstract][Full Text] [Related]
3. Development of 11-DGA-3-
Zhou L; Zou M; Zhu K; Ning S; Xia X
Molecules; 2019 Aug; 24(17):. PubMed ID: 31450608
[TBL] [Abstract][Full Text] [Related]
4. Cantharidin Inhibits Anti-Apoptotic Bcl-2 Family Proteins and Induces Apoptosis in Human Osteosarcoma Cell Lines MG-63 and MNNG/HOS via Mitochondria-Dependent Pathway.
Feng S; Zhu J; Xia K; Yu W; Wang Y; Wang J; Li F; Yang Z; Yang X; Liu B; Tao H; Liang C
Med Sci Monit; 2018 Sep; 24():6742-6749. PubMed ID: 30248086
[TBL] [Abstract][Full Text] [Related]
5. Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways.
Huang WW; Ko SW; Tsai HY; Chung JG; Chiang JH; Chen KT; Chen YC; Chen HY; Chen YF; Yang JS
Int J Oncol; 2011 Apr; 38(4):1067-73. PubMed ID: 21271215
[TBL] [Abstract][Full Text] [Related]
6. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts.
Marianecci C; Paolino D; Celia C; Fresta M; Carafa M; Alhaique F
J Control Release; 2010 Oct; 147(1):127-35. PubMed ID: 20603167
[TBL] [Abstract][Full Text] [Related]
7. Bioactive component, cantharidin from Mylabris cichorii and its antitumor activity against Ehrlich ascites carcinoma.
Verma AK; Prasad SB
Cell Biol Toxicol; 2012 Jun; 28(3):133-47. PubMed ID: 22402807
[TBL] [Abstract][Full Text] [Related]
8. Use of different ligand modification liposomes to evaluate the anti-liver tumor activity of cantharidin.
Zou M; Xu Y; Lin P; Zhou L; Xia X
J Liposome Res; 2023 Sep; 33(3):283-299. PubMed ID: 36594207
[TBL] [Abstract][Full Text] [Related]
9. Liposome encapsulation reduces cantharidin toxicity.
Chang CC; Liu DZ; Lin SY; Liang HJ; Hou WC; Huang WJ; Chang CH; Ho FM; Liang YC
Food Chem Toxicol; 2008 Sep; 46(9):3116-21. PubMed ID: 18652872
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anticancer efficacy of cantharidin by mPEG-PLGA micellar encapsulation: An effective strategy for application of a poisonous traditional Chinese medicine.
Yao H; Zhao J; Wang Z; Lv J; Du G; Jin Y; Zhang Y; Song S; Han G
Colloids Surf B Biointerfaces; 2020 Dec; 196():111285. PubMed ID: 32771818
[TBL] [Abstract][Full Text] [Related]
11. An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers.
Primavera R; Palumbo P; Celia C; Cinque B; Carata E; Carafa M; Paolino D; Cifone MG; Di Marzio L; Cilurzo F
Eur J Pharm Biopharm; 2018 Jun; 127():432-442. PubMed ID: 29605467
[TBL] [Abstract][Full Text] [Related]
12. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
13. Cantharidin induces apoptosis of H460 human lung cancer cells through mitochondria-dependent pathways.
Hsia TC; Yu CC; Hsu SC; Tang NY; Lu HF; Huang YP; Wu SH; Lin JG; Chung JG
Int J Oncol; 2014 Jul; 45(1):245-54. PubMed ID: 24818581
[TBL] [Abstract][Full Text] [Related]
14. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
Hu MH; Huang TT; Chao TI; Chen LJ; Chen YL; Tsai MH; Liu CY; Kao JH; Chen KF
Liver Int; 2018 Dec; 38(12):2248-2259. PubMed ID: 29797403
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of antitumor activity of cantharidin and cantharis peptides].
Liao XY; Lu SG; Feng JF
Zhong Yao Cai; 2013 Oct; 36(10):1566-9. PubMed ID: 24761662
[TBL] [Abstract][Full Text] [Related]
16. Augmented Anticancer Effects of Cantharidin with Liposomal Encapsulation: In Vitro and In Vivo Evaluation.
Zhang X; Lin CC; Chan WK; Liu KL; Yang ZJ; Zhang HQ
Molecules; 2017 Jun; 22(7):. PubMed ID: 28672816
[TBL] [Abstract][Full Text] [Related]
17. cDNA microarray analysis of the effect of cantharidin on DNA damage, cell cycle and apoptosis-associated gene expression in NCI-H460 human lung cancer cells in vitro.
Hsia TC; Yu CC; Hsu SC; Tang NY; Lu HF; Yu CS; Wu SH; Lin JG; Chung JG
Mol Med Rep; 2015 Jul; 12(1):1030-42. PubMed ID: 25815777
[TBL] [Abstract][Full Text] [Related]
18. 18-GA-Suc Modified Liposome Loading Cantharidin for Augmenting Hepatic Specificity: Preparation, Characterization, Antitumor Effects, and Liver-Targeting Efficiency.
Zhu K; Zhou L; Zou M; Ning S; Liu S; Zhou Y; Du K; Zhang X; Xia X
J Pharm Sci; 2020 Jun; 109(6):2038-2047. PubMed ID: 32173319
[TBL] [Abstract][Full Text] [Related]
19. Exploring Cantharidin and its Analogues as Anticancer Agents: A Review.
Li S; Wu X; Fan G; Du K; Deng L
Curr Med Chem; 2023; 30(18):2006-2019. PubMed ID: 36330637
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity.
Yuan Q; Han J; Cong W; Ge Y; Ma D; Dai Z; Li Y; Bi X
Int J Nanomedicine; 2014; 9():4829-46. PubMed ID: 25378924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
